Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by TriVascular, Inc.

evt | Article | September 2015 Supplement

Maintaining Stent Graft Limb Patency

Daniel G. Clair, MD, discusses the risk factors leading to limb failure and device elements that can help diminish this complication.

With Daniel G. Clair, MD

evt | Article | March 2018

Abdominal Aortic Approaches

By Daniel G. Clair, MD, and Timothy A. Resch, MD, PhD

evt | Article | September 2011 Supplement

Advances in Embolic Protection Devices

Will improvements in EPD design lead to safer carotid artery stenting procedures?

By Samir K. Shah, MD; Naveen Balansundaram, MD; and Daniel G. Clair, MD

evt | Article | November 2007

PIVOTAL Trial Update

With enrollment more than half complete, the PIVOTAL trial aims to answer the question of the best treatment model for patients with small aneurysms.

By Daniel G. Clair, MD, and Kenneth Ouriel, MD

Advertisement

evt | Article | March 2012

Off-the-Shelf Devices Should Be Used

Standardized technology allows interventionists to treat patients on an individual basis with the most appropriate device indicated for aneurysm presentations.

By Samir K. Shah, MD; Timothy Resch, MD, PhD; and Daniel G. Clair, MD

evt | News | May 20, 2021

LimFlow System Evaluated in PROMISE I for Treating CLTI

May 20, 2021—LimFlow SA announced that the 12-month data from the full patient cohort in its PROMISE I early feasibility study of the LimFlow percutaneous deep vein arterialization (pDVA) system have been published by Daniel G. Clair, MD, et al in the Journal of Vascular Surgery.

evt | News | January 30, 2012

Endologix's Ventana System Studied for Treatment of Juxtarenal and Pararenal AAAs

January 31, 2012—Endologix, Inc. (Irvine, CA) announced the beginning of enrollment in the company's clinical trial to evaluate the Ventana fenestrated stent graft system for the endovascular repair of juxtarenal and pararenal abdominal aortic aneurysms (AAAs) in the United States.

evt | News | September 5, 2011

Endologix Receives IDE Approval to Study the Ventana Fenestrated Stent Graft System

September 6, 2011—Endologix, Inc. (Irvine, CA) announced that it has received investigational device exemption (IDE) conditional approval from the US Food and Drug Administration to begin clinical trials in the United States to evaluate the Ventana fenestrated stent graft system for the endovascular repair of juxtarenal and pararenal aortic aneurysms.

evt | News | July 7, 2013

Endologix Provides Update of Ventana Fenestrated System Program

July 1, 2013—Endologix, Inc. (Irvine, CA) announced it has completed an initial evaluation of its Ventana clinical trial in the United States that was suspended earlier this year.

evt | News | November 2, 2010

International Trial Begins for the Endologix Ventana Stent Graft

November 2, 2010—Endologix, Inc. (Irvine, CA) announced the first clinical implant of the company's Ventana fenestrated stent graft, which was the first case in the pilot study of this endovascular platform.

evt | Article | March 2012

Chief Medical Editor's Page

More EVAR Options, But Also More Questions

By Ronald M. Fairman, MD, and Edward Y. Woo, MD

evt | News | July 28, 2021

LimFlow’s Percutaneous Deep Vein Arterialization System Studied for Cost-Effectiveness

July 28, 2021—LimFlow SA, a developer of minimally-invasive technology to treat chronic limb-threatening ischemia (CLTI), announced that health economic findings for the LimFlow percutaneous deep vein arterialization (pDVA) system were published by Jan B. Pietzsch, PhD, et al online ahead of print in Journal of Critical Limb Ischemia.

Sponsored by LimFlow, Inc.

evt | Article | May 2021

LimFlow Percutaneous Deep Venous Arterialization

Trial data updates and experiences with latest-generation techniques and technologies.

With Daniel Clair, MD; Mehdi H. Shishehbor, DO, MPH, PhD; Jorge Martínez Trabal, MD, FACS, RPVI; Michiel Schreve, MD; Miguel Montero-Baker, MD; Brian Lepow, DPM; and Roberto Ferraresi, MD

Sponsored by LimFlow, Inc.

evt | Article | May 2020

The Evolving Role of Percutaneous Deep Venous Arterialization

Considerations on the challenge of no-option CLTI, patient candidacy, and clinical experiences to date.

With Daniel Clair, MD; Roberto Ferraresi, MD; Andrej Schmidt, MD; Steven Kum, MD; and Mehdi Shishehbor, DO, MPH, PhD

evt | Article | August 2024

Algorithmic Approaches

By Nicolas J. Mouawad, MD

evt | Article | August 2024

BCLC Staging and Treatment Algorithm: Does It Cover All?

The Barcelona Clinic Liver Cancer staging system is a commonly used algorithm for the management of HCC; however, there are key deviations in contemporary practice.

By Altan Ahmed, MD, MSc; Richard Kim, MD; Daniel A. Anaya, MD, MSHCT, FACS; and Bela Kis, MD, PhD, FSIR

evt | Article | November 2022

The STABILISE Technique for Treatment of Acute/Subacute Type B Dissections

The remodeled single-channeled aorta may prevent aneurysmal degeneration.

By Germano Melissano, MD, and Daniele Mascia, MD

evt | Article | February 2026

From Patient Selection to Fibroid-Level Prediction: Defining the Era of Precision UFE

Advances in imaging, procedural customization, and artificial intelligence are transforming uterine fibroid embolization into a precision medicine intervention, enabling more accurate patient selection, optimized technique, and improved clinical outcomes.

By Dominie Miyasato; Erica M. Knavel Koepsel, MD; Gretchen M. Foltz, MD; and Dania Daye, MD

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button